Skip to main content

Advertisement

Log in

CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women

  • GENETICS
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

The aim of the study was to evaluate the association of CYP1A1 and CYP1B1 polymorphisms with uterine leiomyoma in Chinese women.

Methods

We investigated 100 women with clinically diagnosed uterine leiomyoma and 110 healthy normal subjects from Chinese women. The genetic distribution of two CYP1A1 polymorphisms at MspI, Ile462Val and four CYP1B1 polymorphisms at Arg48Gly, Ala119Ser, Leu432Val, Asp449Asp were analyzed by polymerase chain reaction–restriction fragment length polymorphism and DNA sequencing method.

Results

All the SNPs showed polymorphisms in Chinese women. The genotype A/G and the allele G on Ile462Val was significantly different between uterine leiomyoma patients and controls (P < 0.05).

Conclusion

These results suggest that the genotype of CYP1A1 Ile462Val was associated with the increased risk of uterine leiomyomas in Chinese women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433–45.

    PubMed  Google Scholar 

  2. Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science 2005;308:1589–92. doi:10.1126/science.1112063.

    Article  PubMed  CAS  Google Scholar 

  3. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). Clin Evid. 2005;14:2264–82.

    PubMed  Google Scholar 

  4. Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Updat. 2004;10:207–20. doi:10.1093/humupd/dmh019.

    Article  CAS  Google Scholar 

  5. Jakimiuk AJ, Bogusiewicz M, Tarkowski R, Dziduch P, Adamiak A, Wróbel A, et al. Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women. Fertil Steril. 2004;82:1244–9. doi:10.1016/j.fertnstert.2004.02.130.

    Article  PubMed  CAS  Google Scholar 

  6. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tsai CH. T allele for VEGF-460 gene polymorphism at 5′-untranslated region is associated with higher susceptibility of leiomyoma. Biochem Genet. 2008;46:356–61. doi:10.1007/s10528-008-9150-1.

    Article  PubMed  CAS  Google Scholar 

  7. Morikawa J, Yoshida S, Kennedy S, Takemura N, Sugimoto M, Kitao K, et al. Association study between catechol-O-methyltransferase polymorphisms and uterine leiomyomas in a Japanese population. Clin Exp Obstet Gynecol. 2008;35:35–40.

    PubMed  CAS  Google Scholar 

  8. Nishimura E, Baracat EC, Silva ID. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma. Steroids 2006;71:960–5. doi:10.1016/j.steroids.2006.07.005.

    Article  PubMed  CAS  Google Scholar 

  9. Stiborová M, Martínek V, Rýdlová H, Koblas T, Hodek P. Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers. Cancer Lett. 2005;220:145–54. doi:10.1016/j.canlet.2004.07.036.

    Article  PubMed  CAS  Google Scholar 

  10. Somner J, McLellan S, Cheung J, Mak YT, Frost ML, Knapp KM, et al. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab. 2004;89:344–51. doi:10.1210/jc.2003-030164.

    Article  PubMed  CAS  Google Scholar 

  11. Sowers MR, Wilson AL, Kardia SR, Chu J, McConnell DS. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal. Am J Med. 2006;119:S44–51. doi:10.1016/j.amjmed.2006.07.006.

    Article  PubMed  CAS  Google Scholar 

  12. Corchero J, Pimprale S, Kimura S, Gonzalez FJ. Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics 2001;11:1–6. doi:10.1097/00008571-200102000-00001.

    Article  PubMed  CAS  Google Scholar 

  13. Arvanitis DA, Koumantakis GE, Goumenou AG, Matalliotakis IM, Koumantakis EE, Spandidos DA. CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis. Fertil Steril. 2003;79:702–9. doi:10.1016/S0015-0282(02)04817-3.

    Article  PubMed  Google Scholar 

  14. Watanabe J, Shimada T, Gillam EM, Ikuta T, Suemasu K, Higashi Y, et al. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 2000;10:25–33. doi:10.1097/00008571-200002000-00004.

    Article  PubMed  CAS  Google Scholar 

  15. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res. 2003;63:3913–8.

    PubMed  CAS  Google Scholar 

  16. Aktas D, Guney I, Alikasifoglu M, Yüce K, Tuncbilek E, Ayhan A. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm. Gynecol Oncol. 2002;86:124–8. doi:10.1006/gyno.2002.6720.

    Article  PubMed  CAS  Google Scholar 

  17. Napoli N, Villareal DT, Mumm S, Halstead L, Sheikh S, Cagaanan M, et al. Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J Bone Miner Res. 2005;20:232–9. doi:10.1359/JBMR.041110.

    Article  PubMed  CAS  Google Scholar 

  18. Zhou XJ, Cen XJ, Lu DR. Distribution of the CYP1A1 polymorphisms in Shanghai population. J Kunming Teachers Coll. 2004;26:53–8.

    Google Scholar 

  19. Gallegos-Arreola MP, González-García JR, Figuera LE, Puebla-Pérez AM, Delgado-Lamas JL, Zúñiga-González GM. Distribution of CYP1A12A polymorphism in adult patients with acute lymphoblastic leukemia in a Mexican population. Blood Cells Mol Dis. 2008;41:91–4. doi:10.1016/j.bcmd.2007.12.001.

    Article  PubMed  CAS  Google Scholar 

  20. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Yeh LS, Peng CT. Androgen receptor trinucleotide polymorphism in leiomyoma. J Assist Reprod Genet. 2004;21:453–7. doi:10.1007/s10815-004-8762-6.

    Article  PubMed  Google Scholar 

  21. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol. 1996;36:203–32. doi:10.1146/annurev.pa.36.040196.001223.

    Article  PubMed  CAS  Google Scholar 

  22. Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res. 2000;60:235–7.

    PubMed  CAS  Google Scholar 

  23. Michnovicz JJ, Rosenberg DW. Oxidative metabolism of estrogens in rat intestinal mitochondria. Biochem Pharmacol. 1992;43:1847–52. doi:10.1016/0006-2952(92)90720-4.

    Article  PubMed  CAS  Google Scholar 

  24. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem. 1991;110:407–11.

    PubMed  CAS  Google Scholar 

  25. Crofts F, Cosma GN, Currie D, Taioli E, Toniolo P, Garte SJ. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis 1993;14:1729–31. doi:10.1093/carcin/14.9.1729.

    Article  PubMed  CAS  Google Scholar 

  26. Cascorbi I, Brockmöller J, Roots IA. C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 1996;56:4965–9.

    PubMed  CAS  Google Scholar 

  27. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, et al. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 1994;368:237–9. doi:10.1038/368237a0.

    Article  PubMed  CAS  Google Scholar 

  28. Cushman M, He HM, Katzenellenbogen JA, Lin CM, Hamel E. Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. J Med Chem. 1995;38:2041–9. doi:10.1021/jm00012a003.

    Article  PubMed  CAS  Google Scholar 

  29. Herr D, Bettendorf H, Denschlag D, Keck C, Pietrowski D. Cytochrome P2A13 and P1A1 gene polymorphisms are associated with the occurrence of uterine leiomyoma. Arch Gynecol Obstet. 2006;274:367–71. doi:10.1007/s00404-006-0201-8.

    Article  PubMed  CAS  Google Scholar 

  30. Boyapati SM, Shu XO, Gao YT, Cai Q, Jin F, Zheng W. Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women. Cancer 2005;103:2228–35. doi:10.1002/cncr.21056.

    Article  PubMed  CAS  Google Scholar 

  31. Esinler I, Aktas D, Otegen U, Alikasifoglu M, Yarali H, Tuncbilek E. CYP1A1 gene polymorphism and polycystic ovary syndrome. Reprod Biomed Online. 2008;16:356–60.

    Article  PubMed  CAS  Google Scholar 

  32. Sutter TR, Tang YM, Hayes CL, Wo YY, Jabs EW, Li X, et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem. 1994;269:13092–9.

    PubMed  CAS  Google Scholar 

  33. Han X, Liehr JG. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis 1994;15:997–1000. doi:10.1093/carcin/15.5.997.

    Article  PubMed  CAS  Google Scholar 

  34. Gaudet MM, Chanock S, Lissowska J, Berndt SI, Yang XR, Peplonska B, et al. Genetic variation of cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. Pharmacogenet Genomics. 2006;16:547–53. doi:10.1097/01.fpc.0000215067.29342.6f.

    Article  PubMed  CAS  Google Scholar 

  35. Paracchini V, Raimondi S, Gram IT, Kang D, Kocabas NA, Kristensen VN, et al. Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review. Am J Epidemiol. 2007;165:115–25. doi:10.1093/aje/kwj365.

    Article  PubMed  Google Scholar 

  36. Cho YJ, Hur SE, Lee JY, Song IO, Moon HS, Koong MK, et al. Single nucleotide polymorphisms and haplotypes of the genes encoding the CYP1B1 in Korean women: no association with advanced endometriosis. J Assist Reprod Genet. 2007;24:271–7. doi:10.1007/s10815-007-9122-0.

    Article  PubMed  Google Scholar 

  37. Sillanpää P, Heikinheimo L, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, et al. CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population. Breast Cancer Res Treat. 2007;104:287–97. doi:10.1007/s10549-006-9414-6.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work has been supported by Neijiang First People’s Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yi-Ping Hou.

Additional information

Capsule This is the first report that demonstrates the polymorphism at Ile462Val of CYP1A1 to be associated with uterine leiomyoma in Chinese women.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ye, Y., Cheng, X., Luo, HB. et al. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. J Assist Reprod Genet 25, 389–394 (2008). https://doi.org/10.1007/s10815-008-9246-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-008-9246-x

Keywords

Navigation